Original Research
Accepted on 02 Oct 2023
Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1252215
Type at least 3 characters
1,154 articles
Articles
Original Research
Published on 02 Oct 2023
The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1256720
- 302 views
Original Research
Published on 02 Oct 2023
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1240061
- 320 views
Original Research
Published on 02 Oct 2023
Inflammatory cell death induced by 5-aminolevulinic acid-photodynamic therapy initiates anticancer immunity
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1156763
- 261 views
Case Report
Published on 02 Oct 2023
Severe thyrotoxicosis induced by tislelizumab: a case report and literature review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1190491
- 225 views
Systematic Review
Published on 29 Sep 2023
PD-1/PD-L1 inhibitor treatment and its impact on clinical imaging in non-small cell lung cancer: a systematic review and meta-analysis of immune-related adverse events
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1191681
- 497 views
Mini Review
Accepted on 28 Sep 2023
ROLE OF SEX AND SEX HORMONES IN PD-L1 EXPRESSION IN NSCLC. CLINICAL AND THERAPEUTIC IMPLICATIONS
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1210297
Original Research
Published on 28 Sep 2023
Study of prevalence and risk factors of chemotherapy-induced mucositis in gastrointestinal cancer using machine learning models
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1138992
- 552 views
Review
Accepted on 27 Sep 2023
Spatial Transcriptomics in Glioblastoma: Is Knowing the Right Zip Code the Key to the Next Therapeutic Breakthrough?
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1266397
Systematic Review
Accepted on 26 Sep 2023
Neutrophil-lymphocyte ratio and Platelet-lymphocyte ratio as potential predictive markers of treatment response in cancer patients treated with Immune checkpoint inhibitors; A Systematic Review and Meta-Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1181248
Review
Published on 26 Sep 2023
Circadian rhythm disorders in patients with advanced cancer: a scoping review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1240284
- 332 views
Original Research
Accepted on 25 Sep 2023
Genomic Profiling and Immune Landscape of Olfactory Neuroblastoma in China
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1226494
Original Research
Accepted on 25 Sep 2023
Importance of Metabolic and Immune Profile as a Prognostic Indicator in Patients with Diabetic Clear Cell Renal Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1280618
Review
Accepted on 22 Sep 2023
FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: An Updated Review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1241357
Review
Published on 22 Sep 2023
The role of tumor-associated macrophages in the progression, prognosis and treatment of endometrial cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1213347
- 799 views
Original Research
Published on 22 Sep 2023
A nomogram based on the preoperative neutrophil-to-lymphocyte ratio to distinguish sarcomatoid renal cell carcinoma from clear cell renal cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2023.1218280
- 646 views